Olanzapine-d3 (CAS No 786686-79-1) is used in biomedical research primarily for studying psychotropic drug mechanisms Originating as a deuterated analog of olanzapine its mechanism of action involves antagonism of serotonin 5-HT2A/2C and dopamine D2 receptors This compound demonstrates in vitro activity typically in the nanomolar to low micromolar range indicative of significant receptor affinity Common applications include studies in cell models to evaluate receptor binding as well as in animal models to assess behavioral and physiological outcomes particularly related to antipsychotic effects Additionally Olanzapine-d3 is valuable in drug screening processes enabling researchers to investigate metabolic stability and drug-drug interactions Experimental concentrations typically depend on the specific research design ensuring that findings are relevant to the intended study parameters